HYPERCHOLESTEROLEMIA DRUGS "SHOULD NOT BE SOLD OTC," FDA states in an "guidance for industry" on the "OTC treatment of hypercholesterolemia," released Oct. 2. Issued as a follow-up to the May advisory committee meeting on Bristol-Myers Squibb's Rx-to-OTC switch application for Questran powder for reconstruction, the guidance states that the Center for Drug Evaluation & Research concurs with the advisory committee recommendation that hypercholesterolemia treatment requires both preliminary and ongoing medical management. CDER "therefore believes that drugs for the treatment of hypercholesterolemia should not be sold OTC in the United States."
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
The new FTC chair addressed concerns that staffing cuts will undermine the commission’s commitment to pharmacy benefit manager oversight.
Joint procurement, if used by member states to respond to potential pricing and access challenges caused by a US most favored nations pricing policy, would cause more uncertainty for pharmaceutical companies, warn industry representatives.
Sponsors can expect faster evaluation processes for key medicines and greater support in mitigating medicines supply shortages this year as part of the European Medicines Agency’s digital transformation overhaul.
